Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BLOOD Study: Liraglutide for BP and Lipids in Obese T2D
NCT02503943Phase 4Unknown
- Sponsor
- Army Specialized Medical Center
- Start
- May 2015
- Primary completion
- Sep 2016
- Modality
- Peptides
01
Overview
Phase 4, randomised, open-label trial of liraglutide in type 2 diabetes mellitus (T2DM), hypertension (HTN) and dyslipidemia, sponsored by Army Specialized Medical Center. Status: unknown.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)hypertension (HTN)dyslipidemia
Beyond the preview
Go deeper on NCT02503943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02503943.